Indo US Bio-Tech Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 26.79% vs 14.12% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 54.31% vs -34.33% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 23.29% vs -22.41% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is 23.33% vs -22.08% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Indo US Bio-Tech With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

32.99

58.65

-25.66

-43.75%

Other Operating Income

0.00

Total Operating income

32.99

58.65

-25.66

-43.75%

Raw Material Cost

0.00

56.51

-56.51

-100.00%

Purchase of Finished goods

5.24

0.00

5.24

(Increase) / Decrease In Stocks

12.16

-8.20

20.36

248.29%

Employee Cost

0.33

1.37

-1.04

-75.91%

Power Cost

0.00

Manufacturing Expenses

8.63

0.00

8.63

Selling and Distribution Expenses

0.00

Other Expenses

2.66

3.35

-0.69

-20.60%

Total Expenditure (Excl Depreciation)

29.02

53.03

-24.01

-45.28%

Operating Profit (PBDIT) excl Other Income

3.97

5.62

-1.65

-29.36%

Other Income

0.12

0.07

0.05

71.43%

Operating Profit (PBDIT)

4.09

5.69

-1.60

-28.12%

Interest

0.74

0.76

-0.02

-2.63%

Exceptional Items

0.00

Gross Profit (PBDT)

3.35

4.93

-1.58

-32.05%

Depreciation

0.27

0.46

-0.19

-41.30%

Profit Before Tax

3.08

4.48

-1.40

-31.25%

Tax

0.04

0.39

-0.35

-89.74%

Provisions and contingencies

0.00

Profit After Tax

3.04

4.08

-1.04

-25.49%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3.04

4.08

-1.04

-25.49%

Equity Capital

20.05

10.98

9.07

82.60%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.52

3.72

-2.20

-59.14%

Diluted Earnings per share

1.51

3.72

-2.21

-59.41%

Operating Profit Margin (Excl OI)

12.03%

9.58%

0.00

2.45%

Gross Profit Margin

10.15%

8.41%

0.00

1.74%

PAT Margin

9.21%

6.96%

0.00

2.25%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 32.99 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 26.79% vs 14.12% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.21% vs 24.47% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 3.04 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 54.31% vs -34.33% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -35.32% vs 48.26% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 3.97 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 23.29% vs -22.41% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -27.42% vs 48.24% in Jun 2025

Quarterly - Interest

Interest 0.74 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 23.33% vs -22.08% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 64.44% vs 36.36% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 12.03%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025